Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors

被引:60
|
作者
Chen, B
Petukhov, PA
Jung, M
Velena, A
Eliseeva, E
Dritschilo, A
Kozikowski, AP
机构
[1] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA
[2] Georgetown Univ, Dept Radiat Med, Washington, DC 20057 USA
关键词
histone deacetylase inhibitor; HDAC; mercaptoacetamide;
D O I
10.1016/j.bmcl.2005.01.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of mercaptoacetamides were designed and synthesized as novel histone deacetylase inhibitors with the aid of modeling. Their ability to inhibit HDAC activity and their effects on cancer cell growth were investigated. Some compounds exhibit better HDAC inhibitory activity than SAHA. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1389 / 1392
页数:4
相关论文
共 50 条
  • [31] Quinazolines as novel anti-inflammatory histone deacetylase inhibitors
    Lin, Zhigang
    Murray, Pamela M.
    Ding, Yaoyao
    Denny, William A.
    Ferguson, Lynnette R.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 690 (1-2) : 81 - 88
  • [32] Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas
    Manta, Aspasia
    Kazanas, Spyridon
    Karamaroudis, Stefanos
    Gogas, Helen
    Ziogas, Dimitrios C.
    ONCOLOGY RESEARCH, 2022, 30 (05) : 211 - 219
  • [33] Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors
    Binaschi, Monica
    Boldetti, Andrea
    Gianni, Maurizio
    Maggi, Carlo Alberto
    Gensini, Martina
    Bigioni, Mario
    Parlani, Massimo
    Giolitti, Alessandro
    Fratelli, Maddalena
    Valli, Claudia
    Terao, Mineko
    Garattini, Enrico
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (08): : 411 - 415
  • [34] Novel histone deacetylase (HDAC) inhibitors that promote cardiac differentiation
    Shaw, Stanley Y.
    Nakamaru, Kenji
    Tang, Weiping
    Luo, Tuoping
    Fass, Daniel
    Bradner, Jay
    Haggarty, Stephen
    Schreiber, Stuart
    CIRCULATION RESEARCH, 2006, 99 (11) : 1282 - 1282
  • [35] Virtual screening and experimental validation of novel histone deacetylase inhibitors
    Yan-xin Huang
    Jian Zhao
    Qiu-hang Song
    Li-hua Zheng
    Cong Fan
    Ting-ting Liu
    Yong-li Bao
    Lu-guo Sun
    Li-biao Zhang
    Yu-xin Li
    BMC Pharmacology and Toxicology, 17
  • [36] ORGN 342-Development of novel histone deacetylase inhibitors
    Cook, Gregory R.
    Kaneko, Miho
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [37] Differential protein acetylation induced by novel histone deacetylase inhibitors
    Glaser, KB
    Li, J
    Pease, LJ
    Staver, MJ
    Marcotte, PA
    Guo, J
    Frey, RR
    Garland, RB
    Heyman, HR
    Wada, CK
    Vasudevan, A
    Michaelides, MR
    Davidsen, SK
    Curtin, ML
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (03) : 683 - 690
  • [38] Heteroaryl hydroxamic acid derivatives as novel histone deacetylase inhibitors
    Shirai, Fumiyuki
    Mukoyoshi, Koichiro
    Urano, Yasuharu
    Eikyu, Yoshiteru
    Ishibashi, Naoki
    Sawada, Yuki
    Kamijo, Kazunori
    Kozuki, Yoshihiro
    Satoh, Shigeki
    Masunaga, Taro
    Ohkubo, Mitsuru
    Ohta, Mitsuaki
    Tsukamoto, Shinichi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [39] Novel hydroxamate and non-hydroxamate histone deacetylase inhibitors
    Curtin, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
  • [40] A novel series of potent and selective histone deacetylase inhibitors.
    Jones, Philip
    Altamura, Sergio
    Chakravarty, Prasun K.
    Ingenito, Raffaele
    Petrocchi, Alessia
    Rowley, Michael
    Scarpelli, Rita
    Serafini, Sergio
    Steinkuhler, Christian
    CANCER RESEARCH, 2006, 66 (08)